Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

414 participants

Study Classification

OBSERVATIONAL

Study Start Date

2002-03-31

Study Completion Date

2011-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research study is to assess outcomes of treatment for early prostate cancer. Current treatments for early (non-metastatic) cancer may cause long-term impairments in the patients quality of life. In this study we will compare the outcomes of patients treated with two alternative brachytherapy (seed implants) techniques using a series of questionnaires.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Brachytherapy for Prostatic Carcinoma Patients

NCT00525720

Prostate Cancer

ACTIVE_NOT_RECRUITING PHASE2

Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer

NCT00714753

Prostate Cancer

COMPLETED PHASE2

Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate

NCT01508390

Prostate Cancer

ACTIVE_NOT_RECRUITING NA

Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer

NCT01354951

Prostate Cancer

TERMINATED PHASE2

Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer

NCT00063882

Prostate Cancer

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Participants will be asked to complete a questionnaire about their health prior to treatment, at 1, 3 and 12 months after treatment and then once a year 4 more times.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MRBT

MRI-assisted brachytherapy, the experimental arm

brachytherapy

Intervention Type RADIATION

An experimental arm using MRI imaging and excluding the transition zone from the target volume

USBT1

Standard ultrasound-guided brachytherapy performed by group 1 (control arm 1)

brachytherapy

Intervention Type RADIATION

Standard ultrasound-guided brachytherapy with standard target volumes

USBT2

Standard ultrasound-guided brachytherapy performed by group 2 (control group 2)

brachytherapy

Intervention Type RADIATION

Standard ultrasound-guided brachytherapy with standard target volumes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

brachytherapy

An experimental arm using MRI imaging and excluding the transition zone from the target volume

Intervention Type RADIATION

brachytherapy

Standard ultrasound-guided brachytherapy with standard target volumes

Intervention Type RADIATION

brachytherapy

Standard ultrasound-guided brachytherapy with standard target volumes

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pathological diagnosis of an adenocarcinoma of the prostate
* 18 years of age or older
* Prior choice of either standard brachytherapy or MRIGPB as primary treatment